CUE · Categories · Form 4
CUE - SEC Form 4 insider transactions
Cue Biopharma Inc. (CUE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CUE
- SEC Form 4 filed by Director Meehan Viola Mong4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- CHIEF EXECUTIVE OFFICER Lin Shao-Lee was granted 327,537 shares (SEC Form 4)4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Warren Lucinda4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Baker Daniel G.4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Broadfoot Jill Marie4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Garzone Pamela4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Kiener Peter A4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Sarraf Pasha4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Verheyen Patrick4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Morich Frank4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Azam Usman4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Broadfoot Jill Marie4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Millar Kerri-Ann4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Passeri Daniel R4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Levisetti Matteo4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Sarraf Pasha4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Morich Frank4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Kiener Peter A4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Verheyen Patrick4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Driscoll Frederick W4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Director Garzone Pamela4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Fox Michael J4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Levisetti Matteo4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Suri Anish4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Millar Kerri-Ann4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Millar Kerri-Ann4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Suri Anish4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Levisetti Matteo4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Passeri Daniel R4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Levisetti Matteo4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Garzone Pamela4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Kiener Peter A4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Driscoll Frederick W4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Verheyen Patrick4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Morich Frank4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4: Suri Anish bought $11,040 worth of shares (4,000 units at $2.76), increasing direct ownership by 3% to 135,638 units4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4: Passeri Daniel R bought $8,580 worth of shares (3,000 units at $2.86), increasing direct ownership by 2% to 134,578 units4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Levisetti Matteo4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Millar Kerri-Ann4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Passeri Daniel R4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Suri Anish4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Garzone Pamela4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Verheyen Patrick4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Kiener Peter A4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Nasshorn Patricia4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Suri Anish4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Sandercock Colin4 - Cue Biopharma, Inc. (0001645460) (Issuer)
- SEC Form 4 filed by Passeri Daniel R4 - Cue Biopharma, Inc. (0001645460) (Issuer)